Takeda Pharmaceutical (TAK) News Today

SourceHeadline
finance.yahoo.com logoAAVantgarde announces updated NHP data from its Stargardt disease program in a poster presentation at the ARVO 2024 annual meeting
finance.yahoo.com - April 24 at 2:04 AM
msn.com logoNeurocrine Biosciences Says Treatment Can Alleviate Several Symptoms Associated With Depressive Disorder
msn.com - April 23 at 4:03 PM
msn.com logoNeurocrine succeeds in mid-stage trial for Takeda-partnered depression drug
msn.com - April 23 at 4:03 PM
finance.yahoo.com logoTakeda Pharmaceutical: A Long-Term Cash Cow
finance.yahoo.com - April 23 at 11:02 AM
msn.com logoTop pharmaceutical company evaluates Optimer for precision liver medicine
msn.com - April 22 at 9:11 AM
investing.com logoFDA approves Takeda's ENTYVIO for Crohn's disease
investing.com - April 18 at 11:05 PM
markets.businessinsider.com logoFDA Approves Subcutaneous Administration Of Takeda's Entyvio For Crohn's Disease
markets.businessinsider.com - April 18 at 11:05 PM
marketwatch.com logoTakeda Says FDA Has Approved Subcutaneous Entyvio for Crohn's Disease
marketwatch.com - April 18 at 11:05 PM
finance.yahoo.com logoTakeda Pharmaceutical Company Limited (TKD.VI)
finance.yahoo.com - April 18 at 7:59 AM
seekingalpha.com logoJazz Pharmaceuticals: Targeting The Low-Hanging Fruit In Oncology Might Pay Off
seekingalpha.com - April 15 at 7:51 AM
bizjournals.com logoViewpoint: To stay on top, Boston must lead pharma’s transformation
bizjournals.com - April 12 at 8:49 AM
benzinga.com logoAssessing Johnson & Johnson's Performance Against Competitors In Pharmaceuticals Industry
benzinga.com - April 11 at 8:01 AM
stockhouse.com logoLigand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI(TM)
stockhouse.com - April 3 at 10:57 AM
msn.com logoThis could be the worst year yet for dengue in the Americas
msn.com - March 30 at 4:05 AM
finance.yahoo.com logoEphicacy Bolsters Leadership Team with Four New Hires
finance.yahoo.com - March 27 at 2:35 PM
finanznachrichten.de logoTakeda Pharmaceuticals: Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE
finanznachrichten.de - March 27 at 9:35 AM
markets.businessinsider.com logoScilex, Takeda Settle Paragraph IV Patent Infringement Lawsuit - Quick Facts
markets.businessinsider.com - March 20 at 3:50 PM
markets.businessinsider.com logoTakeda: Mezagitamab Phase 2 Trial Shows Positive Results In Primary Immune Thrombocytopenia
markets.businessinsider.com - March 13 at 1:21 PM
msn.com logoUniversity Of Strathclyde Invites Applications For MSc Advanced Pharmaceutical Manufacturing Course Starting September 2024
msn.com - March 13 at 8:20 AM
finance.yahoo.com logoTakeda Pharmaceutical Co Ltd (TKD.HM)
finance.yahoo.com - February 28 at 10:15 AM
msn.com logoTakeda and Biological E partner to boost dengue vaccine production in India
msn.com - February 28 at 10:15 AM
finance.yahoo.com logoCholera Vaccines Market to Reach USD 167.3 Million by 2030, Fueled by a CAGR of 9.0% from 2030 | MarketDigits
finance.yahoo.com - February 27 at 8:54 AM
sg.finance.yahoo.com logoTakeda Accelerates Access to its Dengue Vaccine Through 'Make in India' Manufacturing Partnership with Biological E.
sg.finance.yahoo.com - February 27 at 1:21 AM
markets.businessinsider.com logoTakeda Signs Manufacturing Partnership With India's Biological E. For Dengue Vaccine QDENGA
markets.businessinsider.com - February 27 at 1:21 AM
news.yahoo.com logoJapan's Takeda partners with India's Biological E. to boost dengue vaccine production
news.yahoo.com - February 27 at 1:21 AM
finance.yahoo.com logoNasdaq DM Asia Health Care Larg (^NQDMASIA20LMGBP)
finance.yahoo.com - February 25 at 6:39 PM
forbes.com logoA Decade Of Innovation: How This CEO Transformed A Global Pharma Giant
forbes.com - February 23 at 5:16 PM
investing.com logoTakeda Pharmaceutical Co Ltd ADR (TAK)
investing.com - February 20 at 10:34 PM
finance.yahoo.com logoLigand Pharmaceuticals Expands Senior Leadership Team with Two Key Hires
finance.yahoo.com - February 16 at 9:00 AM
msn.com logoFDA Approves Takeda's Eohilia As First Oral Treatment For Inflammed Esophagus
msn.com - February 12 at 5:42 PM
markets.businessinsider.com logoCentessa Pharmaceuticals: Buy Rating Backed by Strong Pipeline and Positive Drug Data
markets.businessinsider.com - February 12 at 12:41 PM
markets.businessinsider.com logoTakeda Says FDA Approves EOHILIA To Treat Eosinophilic Esophagitis
markets.businessinsider.com - February 12 at 12:41 PM
reuters.com logoTakeda's treatment becomes first oral therapy for esophageal condition in US
reuters.com - February 12 at 12:41 PM
msn.com logoEU okays Takeda's Hyqvia co-formulated with Halozyme's Enhanze
msn.com - January 31 at 10:02 AM
finance.yahoo.com logoCour gets $105M, pharma help to ‘reprogram’ autoimmune disease
finance.yahoo.com - January 30 at 3:17 PM
markets.businessinsider.com logoTakeda's Hyqvia Approved In Europe For Chronic Inflammatory Demyelinating Polyneuropathy
markets.businessinsider.com - January 29 at 7:27 AM
benzinga.com logoCompetitor Analysis: Evaluating Pfizer And Competitors In Pharmaceuticals Industry
benzinga.com - January 22 at 5:03 PM
barrons.com logoBrazil To Launch Vaccination Campaign As Dengue Surges
barrons.com - January 22 at 5:03 PM
finance.yahoo.com logoPDS Biotech Announces Retirement of Lauren V. Wood, M.D., and Appointment of Kirk V. Shepard, M.D., as Chief Medical Officer
finance.yahoo.com - January 22 at 5:03 PM
msn.com logoNew ADHD drugs could pay off for pharmaceutical companies
msn.com - January 21 at 3:09 PM
msn.com logoTakeda gains FDA approval for HYQVIA to treat CIDP
msn.com - January 17 at 1:04 PM
finance.yahoo.com logoPlexium Announces Appointment of Michael Martin, Ph.D. as President and CEO
finance.yahoo.com - January 16 at 10:47 AM
msn.com logoPfizer, Takeda Among Pharma Companies Raising Prices on Over 500 Drugs in January: Report
msn.com - December 29 at 5:20 PM
msn.com logoExpensive Drugs For Americans In 2024? Drugmakers Including Pfizer, Sanofi Mull Price Increase In January
msn.com - December 29 at 12:20 PM
msn.com logoPfizer, big drugmakers expected to hike prices on at least 500 drugs in January
msn.com - December 29 at 12:20 PM
reuters.com logoExclusive: Drugmakers set to raise US prices on at least 500 drugs in January
reuters.com - December 29 at 12:20 PM
markets.businessinsider.com logoChina Approves Takeda's Post-transplant Cytomegalovirus Treatment
markets.businessinsider.com - December 22 at 12:19 AM
bbc.com logoShire rejects £43bn offer from Japan's Takeda
bbc.com - December 21 at 4:17 AM
bbc.com logoShire recommends Takeda's revised £46bn takeover offer
bbc.com - December 19 at 12:29 PM
msn.com logoSeagen lymphoma drug shows 100% progression free survival in Phase 2 trial
msn.com - December 11 at 12:18 PM
Get Takeda Pharmaceutical News Delivered to You Automatically

Sign up to receive the latest news and ratings for TAK and its competitors with MarketBeat's FREE daily newsletter.

“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)

See this before next week's Fed Meeting Thousands of investing ideas come across his desk every year… But Doc Eifrig just revealed THIS ONE "will go down as one of the smartest and most lucrative financial moves of the decade." (Last time we shared this, it led to a 995% gain.)

Get the free details now.

TAK Media Mentions By Week

TAK Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TAK
News Sentiment

0.35

0.57

Average
Manufacturing
News Sentiment

TAK News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TAK Articles
This Week

8

3

TAK Articles
Average Week

Get Takeda Pharmaceutical News Delivered to You Automatically

Sign up to receive the latest news and ratings for TAK and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (CVE:TAK) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners